HeartSciences Financials - Benzinga

HeartSciences Inc

HSCSNASDAQ

Trade with Public

Trade with Public

$4.73

0.102.16%

À la clôture: Sep 25, 5:00 PM EST

$4.66

-0.07-1.48%

Après les heures: Sep 25, 5:46 PM EST

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Rapport sur les stocks

HeartSciences Financials

HeartSciences (HSCS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Heart Test Laboratories Q1 EPS $(0.86) Up From $(1.58) YoY, Sales $2.100K Up From $1.900K YoY

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.86) per share. This is a 45.57 percent increase over losses of $(1.58) per share from the same period last year. The company reported $2.100

Benzinga Newsdesk

PRO
Heart Test Laboratories Q4 EPS $(0.87) Misses $(0.73) Estimate

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.73) by 19.18 percent. This is a 53.23 percent increase over losses of $(1.86) per

Benzinga Newsdesk

PRO
Heart Test Laboratories Q3 EPS $(0.63) Beats $(0.86) Estimate

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.86) by 26.74 percent. This is a 75.49 percent increase over losses of $(2.57) per

Benzinga Newsdesk

PRO
CORRECTION: Heart Test Laboratories Q2 EPS $(0.85) Beats $(1.69) Estimate, Sales $2.419K Miss $50.000K Estimate

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.69) by 49.7 percent. This is a 62.56 percent increase over losses of $(2.27) per share

Benzinga Newsdesk

PRO
Heart Test Laboratories Q2 EPS $(0.85) Beats $(1.69) Estimate, Sales $2.419M Beat $50.000K Estimate

Benzinga Newsdesk

PRO
HeartSciences Q1 EPS $(1.58) Beats $(2.09) Estimate, Sales $1.900M

HeartSciences Inc. (NASDAQ:HSCS) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(2.09) by 24.4 percent. This is a 40.15 percent increase over losses of $(2.64) per share from

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved